Oral lactoferrin as a treatment of pediatrics’ anemia resulted from chronic kidney diseases: a randomized controlled trial
Abstract Anemia in pediatrics is often associated with chronic conditions such as chronic kidney disease (CKD). It can worsen the disease prognosis and affect quality of life. Injectable dosage forms are predominantly used in its treatment with various side effects. This randomized and parallel clin...
Saved in:
Main Authors: | Sahar Kamal Hegazy, Mai Salah El-Din Koura, Mohamed Shokry Elharoun |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-88506-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lactoferrin: a secret weapon in the war against pathogenic bacteria
by: Lucero Ruiz-Mazón, et al.
Published: (2024-10-01) -
Association of iron deficiency with kidney outcome and all-cause mortality in chronic kidney disease patients without anemia
by: Hongxue Yu, et al.
Published: (2025-01-01) -
Research Progress in Lactoferrin’s Role in Alleviating Intestinal Barrier Dysfunction
by: LI Yi, REN Xinxin, WANG Qin, HE Xiaoyun
Published: (2025-01-01) -
Enteric Coated Pellets with Lactoferrin for Oral Delivery: Improved Shelf Life of the Product
by: Nika Kržišnik, et al.
Published: (2024-12-01) -
Early CBC Screening for Detecting Subclinical Anemia in Adolescent Females
by: Saadia Saad, et al.
Published: (2025-01-01)